Literature DB >> 3157419

Severe cutaneous reactions to captopril.

M J Goodfield, L G Millard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157419      PMCID: PMC1418714          DOI: 10.1136/bmj.290.6475.1111

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Eosinophilia during captopril treatment.

Authors:  J G Kayanakis; P Giraud; J M Fauvel; J P Bounhoure
Journal:  Lancet       Date:  1980-10-25       Impact factor: 79.321

2.  Captopril: five years on.

Authors:  G P Hodsman; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

3.  The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation.

Authors:  J K Wilkin; J J Hammond; W M Kirkendall
Journal:  Arch Dermatol       Date:  1980-08

4.  Exfoliative dermatitis from captopril.

Authors:  A M Solinger
Journal:  Cutis       Date:  1982-05
  4 in total
  8 in total

1.  Adverse drug reactions leading to hospital admission.

Authors:  L Ibáñez; J R Laporte; X Carné
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

2.  Does captopril exacerbate psoriasis?

Authors:  N W Hamlet; M Keefe; R E Kerr
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-21

3.  [Results of a 5-year study with captopril in patients with severe therapy-resistant hypertension].

Authors:  J Schrader; G Schoel; F Scheler
Journal:  Klin Wochenschr       Date:  1986-08-01

Review 4.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

5.  Severe cutaneous reactions to captopril and enalapril; histological study and comparison with early mycosis fungoides.

Authors:  P N Furness; M J Goodfield; K A MacLennan; A Stevens; L G Millard
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

Review 6.  ACE inhibitor-induced angioedema. Incidence, prevention and management.

Authors:  W Vleeming; J G van Amsterdam; B H Stricker; D J de Wildt
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

7.  Captopril: 4 years of post marketing surveillance of all patients in New Zealand.

Authors:  I R Edwards; D M Coulter; D M Beasley; D MacIntosh
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

Review 8.  Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. A research review.

Authors:  B R Lindgren; R G Andersson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.